Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 0.600nM ΔG°: -12.6kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 1.30nM ΔG°: -12.1kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 1.40nM ΔG°: -12.1kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 2.70nM ΔG°: -11.7kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 2.80nM ΔG°: -11.7kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 3nM ΔG°: -11.6kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 3.30nM ΔG°: -11.6kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 3.70nM ΔG°: -11.5kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 3.80nM ΔG°: -11.5kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 5.40nM ΔG°: -11.3kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 5.40nM ΔG°: -11.3kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 5.60nM ΔG°: -11.2kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 6nM ΔG°: -11.2kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 6nM ΔG°: -11.2kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 6.5nM ΔG°: -11.2kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 6.80nM ΔG°: -11.1kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 9.30nM ΔG°: -10.9kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 9.90nM ΔG°: -10.9kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 11nM ΔG°: -10.8kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 25nM ΔG°: -10.4kcal/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 1.70E+5nMAssay Description:Inhibition of dihydrodipicolinate synthaseMore data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 1.70E+5nMAssay Description:Inhibition of dihydrodipicolinate synthaseMore data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 3.30E+5nMAssay Description:Inhibition of dihydrodipicolinate synthaseMore data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 2.96E+6nMAssay Description:Inhibition of dihydrodipicolinate synthaseMore data for this Ligand-Target Pair
Target4-hydroxy-2-oxoglutarate aldolase, mitochondrial(Homo sapiens (Human))
Alectos Therapeutics
US Patent
Alectos Therapeutics
US Patent
Affinity DataKi: 1.10E+7nMAssay Description:Inhibition of dihydrodipicolinate synthaseMore data for this Ligand-Target Pair